HONG KONG SAR - Media OutReach Newswire - 3 May 2024 - The Society of Publishers in Asia (SOPA), a Hong Kong-based not-for-profit organization dedicated to
SOPA Announces 2024 Journalism Awards Finalists sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
HONG KONG SAR - Media OutReach Newswire - 12 December 2023 - The Society of Publishers in Asia (SOPA) , a not-for-profit organization dedicated to the pursuit of excellence in journalism, announced today that the SOPA 2024 Awards for Editorial Excellence are open for entries. The deadline for submissions is 3pm Hong Kong time on Thursday February 22nd, 2024. The.
Using the ‘power of information’ to change the world
Yi-Shan Chen, ICIJ’s member from Taiwan, witnessed the power of information through martial law and the Tiananmen Square protests. Now, as a journalist, she aims to harness that power for the people. March 15, 2021
The International Consortium of Investigative Journalists collaborates with hundreds of members across the world. Each of these journalists is among the best in his or her country and many have won national and global awards. Our monthly series, Meet the Investigators, highlights the work of these tireless journalists.
Yi-Shan Chen is the deputy managing editor at CommonWealth Magazine in Taiwan, where she started her career in 1996 before joining the China Times. Chen, whose background is in economics, has partnered with the International Consortium of Investigative Journalists on several investigations over the years, including Offshore Leaks and The Panama Papers.
E-Mail
University of Illinois Chicago is one of the U.S. sites participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients blood cells.
The first cases treated with this approach were recently published in an article co-authored by Dr. Damiano Rondelli, the Michael Reese Professor of Hematology at the UIC College of Medicine. The article reports two patients have been cured of beta thalassemia and sickle cell disease after their own genes were edited with CRISPR-Cas9 technology. The two researchers who invented this technology received the Nobel Prize in Chemistry in 2020.